Home › COPD › California › Long Beach
COPD clinical trials in Long Beach, CA
3 studies for COPD are looking for participants at sites in and around Long Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Long Beach Research Institute- Site Number : 8400027, Long Beach
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Ark Clinical Research- Site Number : 8400113, Long Beach
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, Long Beach
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA22 studies
- Miami, FL18 studies
- Birmingham, AL18 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Chicago, IL14 studies
- Pittsburgh, PA13 studies
- Baltimore, MD13 studies
- Dallas, TX12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in Long Beach
- Non-Small Cell Lung Cancer12 studies
- Type 2 Diabetes11 studies
- Breast Cancer9 studies
- Lung Cancer9 studies
- Alzheimer's Disease8 studies
- Prostate Cancer7 studies
- Cancer (all types)6 studies
- Cardiovascular Disease6 studies
- Dementia5 studies
- Obesity5 studies
- Overweight5 studies
- Chronic Lymphocytic Leukemia4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.